Back to results
US 2023/0414506 A1Published application
Peptide formulations and methods of use
AssigneeRealta Life Sciences, Inc.
InventorsNeel K. KRISHNA, Kenji CUNNION
Life of this patent
Estimating the term…
Abstract
The present invention provides synthetic peptides. The invention is directed to modifications of a synthetic peptide of 15 amino acids from the Polar Assortant (PA) peptide, which is a scrambled peptide derived from human Astrovirus protein. In some embodiments, the invention is directed to pharmaceutical formulations of the peptides including lipid-based formulations and formulations suitable for intravenous administration.
Claims23
A composition comprising a therapeutically effective amount of SEQ ID NO:
- 3 and a lipid-based carrier.
A composition comprising a therapeutically effective amount of SEQ ID NO:
- 2 or SEQ ID NO:
- 3 and at least one excipient.
Dependencies are inferred from the claim text.